BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22336752)

  • 21. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
    Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
    J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.
    Inai T; Mancuso M; Hashizume H; Baffert F; Haskell A; Baluk P; Hu-Lowe DD; Shalinsky DR; Thurston G; Yancopoulos GD; McDonald DM
    Am J Pathol; 2004 Jul; 165(1):35-52. PubMed ID: 15215160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
    Albrecht I; Kopfstein L; Strittmatter K; Schomber T; Falkevall A; Hagberg CE; Lorentz P; Jeltsch M; Alitalo K; Eriksson U; Christofori G; Pietras K
    PLoS One; 2010 Nov; 5(11):e14109. PubMed ID: 21124841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.
    Oh SH; Kim WY; Lee OH; Kang JH; Woo JK; Kim JH; Glisson B; Lee HY
    Cancer Sci; 2012 Jul; 103(7):1259-66. PubMed ID: 22494072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
    Zhang C; Lu L; Li Y; Wang X; Zhou J; Liu Y; Fu P; Gallicchio MA; Bach LA; Duan C
    Int J Cancer; 2012 May; 130(9):2003-12. PubMed ID: 21618524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.
    Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M
    Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
    Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
    Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis.
    Okazaki T; Ebihara S; Takahashi H; Asada M; Kanda A; Sasaki H
    J Immunol; 2005 Jun; 174(12):7531-8. PubMed ID: 15944252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
    Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
    J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.